Nivolumab,Ipilimumab
BMS
[]
such an amazing presidential session on neoadjuvant/adjuvant io approaches across cancer types. not at but learning and cheering from this side of the world! #jameslarkin #shereneloi #jean-pascalmachiels 
GU oncologist, clinical trialist, Director GU Oncology @CleclinicMD Tweets my own, RT/Likes not active endorsement.